Antiemetic Drugs Market Size, Share, Analysis, Industry Report and Forecast 2021-2027
The global antiemetic drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Antiemetic drugs are the medications that are used to treat nausea and vomiting. Both of these conditions are generally the symptoms of several medical issues such as food poisoning, pregnancy, motion sickness, dizziness, and sometimes even emotional stress. Adding to this, antiemetics drugs are also used for the treatment of the side effects of other medications such as chemotherapy, opioid analgesics, and general anesthetics.
Further, growing geriatric population along with the rising
prevalence of cancer as well as the growing number of gastroenteritis patients
are also acting as the pivotal factors contributing to the increased demand for
these drugs. The global antiemetic drugs market is also driven by extensive
R&D along with new FDA approvals. For instance, in April 2021, Caplin
Steriles has been granted final approval from the US FDA for its abbreviated
new drug application (ANDA) prochlorperazine edisylate injection USP, 10 mg/2
mL (5 mg/mL) vials. Prochlorperazine edisylate injection is an antiemetic drug
that is indicated for the control of severe nausea and vomiting.
To Request a Sample of our Report on Antiemetic Drugs Market: https://www.omrglobal.com/request-sample/antiemetic-drugs-market
Some major players in the market include GlaxoSmithKline
plc, Merck & Co., Inc., and Novartis International AG, among others. These
market players are contributing significantly to the growth of the market by
the adoption of various strategies including mergers and acquisitions,
geographical expansion, partnerships and collaborations, and new product
launches, to stay competitive in the market. For instance, in November 2021,
Heron Therapeutics, Inc. announced the submission of its New Drug Application
(NDA) to the US Food and Drug Administration (FDA) for HTX-019 (aprepitant)
injectable emulsion. HTX-019 injectable emulsion is intended to be used for the
prevention of postoperative nausea and vomiting (PONV) in adults.
Market
Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
·
By Drug Class
·
By Application
• Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
•
Competitive Landscape:
GlaxoSmithKline plc, Merck & Co., Inc., and Novartis International AG,
among others.
(Get 15% Discount on Buying this Report)
A
full Report of Antiemetic Drugs Market is Available @ https://www.omrglobal.com/industry-reports/antiemetic-drugs-market
Global Antiemetic Drugs Market Report by Segment
By
Drug Class
• 5-HT3 Receptor Antagonists
• Dopamine Antagonists
• NK1 Receptor Antagonists
• H1 Receptor Antagonists
• Cannabinoids
• Benzodiazepines
• Anticholinergics
• Steroids
By
Application
• Motion Sickness
• Dizziness
• General Anesthetics
• Others
Global
Antiemetic Drugs Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment